.svg){kind=small}
Mar-2024
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the ever-evolving cannabis market, Fairwinds has demonstrated notable performance across several categories and states, with a particularly strong presence in Washington. In Washington, Fairwinds has maintained top positions in the Tincture & Sublingual and Capsules categories, securing the 1st and 2nd ranks respectively through the first quarter of 2024. This consistency not only underscores the brand's dominance in these categories but also reflects a steady demand for their products. The brand's performance in the Topical category, holding the 3rd position consistently, further solidifies its market presence. However, it's worth noting a significant variance in their performance in the Vapor Pens category, where they lingered around the 66th position, indicating a lesser impact in that space compared to their stronghold in others.
Outside of Washington, Fairwinds' performance has been mixed. In Colorado, the brand ranked 16th in the Tincture & Sublingual category in December 2023 but did not make it into the top 30 in the following months, suggesting a potential decline in market share or increased competition. Conversely, in Massachusetts, Fairwinds showed a positive trajectory in the Capsules category, improving from the 7th position in December 2023 to the 5th by March 2024. This improvement indicates a growing foothold in Massachusetts, contrasting with their challenges in Colorado. The brand's ability to maintain and improve its rankings in Massachusetts, alongside its strong performance in Washington, showcases its strategic market positioning and adaptability across different regions, although the absence from top rankings in certain months and categories highlights areas for potential growth or reevaluation.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in Washington, Fairwinds has consistently maintained its top position from December 2023 through March 2024, showcasing a steady increase in sales and solidifying its market dominance. Its closest competitor, Green Revolution, held the second rank during the same period but experienced a fluctuation in sales, with a notable dip in January and February 2024 before rebounding in March. This rebound, however, was not enough to challenge Fairwinds' leading position, despite Green Revolution closing the sales gap in March. The third-place contender, Ceres, also saw a decline in sales in the early months of 2024, with a slight recovery in March, but remained significantly behind in both rank and sales volume compared to Fairwinds and Green Revolution. This analysis underscores Fairwinds' strong market presence and resilience in sales performance, positioning it well ahead of its competitors in the Tincture & Sublingual category within the Washington market.
Notable Products
In March 2024, Fairwinds saw its CBD/CBN/THC 5:5:1 Deep Sleep Tincture leading the sales with 2177 units, maintaining its top position from previous months. Following closely, the CBD/THC 1:1 Ratio Tincture climbed to the second spot with a notable increase in sales, showcasing its growing popularity. The CBD/THC/CBG 1:1:1 Flow Cream Deep Tissue Relief secured the third rank, indicating a consistent demand for topical solutions among consumers. Additionally, the CBD/THC/CBN 10:2:10 Deeper Sleep Plus CBN Capsule made it to the fourth position, reflecting a steady interest in capsule forms for sleep aid. Lastly, the CBD/THC 5:1 Companion Savory Bacon Tincture emerged as the fifth best-selling product, marking its debut in the top ranks for the month.
Top Selling Cannabis Brands
